Form EFFECT Milestone Pharmaceutical
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 22, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Milestone Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 12, 2026
- InvestorNewsBreaks – SKYX Platforms Corp. (NASDAQ: SKYX) to Host Q2 2026 Earnings Call Aug. 12
- American Water Joins Dialogue at 2026 American Society of Civil Engineers Watershed Management Conference
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
